fashion -WSS

fashion

author：comprehensive 2025-09-14 06:49:42 - browse：7765

Senator Ron Wyden. -- health policy coverage from STAT — Sen. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee Mariam Zuhaib/AP

WASHINGTON — A key Senate committee is proposing that Medicare pay bonuses to hospitals that take measures to prevent drug shortages. It also wants to change the way doctors are paid to administer drugs in outpatient settings.

After a startling number of drugs, including chemotherapies, were in shortage last year, Washington stepped up its efforts to find policy solutions for the problems.

Most experts say the way that Medicare pays hospitals and doctors, along with the dominance of group purchasing organizations that buy hospital drugs, together force generic drugmakers to cut prices for cheaper generics so low that there is no money left for maintaining facilities or using reliable, diversified supply chains. The result is that facilities get shut down or generic drug manufacturers exit markets, leaving too few makers of drugs to supply demand.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Why CTE doesn’t keep Americans from enjoying the Super Bowl

focus

WSS

Analysis of telehealth claims data suggest service duplication

Why Novartis is going to walk from its acquisition of MorphoSys

Adopting new red light myopia treatments may be short

Readout LOUD: Venture capital, Gilead, and more M&A

Bernie brings in new pharma CEOs to talk drug prices

Surgery pushed Ben Carson to fame

Wikipedia

fashion

entertainment

Drug repurposing or repositioning? The language matters

Was Amgen transparent enough on FDA's concern on cancer drug?

Peter Hotez and the public health issue of online harassment

FDA rejects Alnylam's heart disease treatment over insufficient data

The cancer drug shortage isn’t new — and neither are the solutions

Sana to lay off nearly a third of staff, de

Duchenne breakthrough therapy leaves behind pioneering families

Chemotherapy drug shortage eases slightly but still widespread

Wildfire smoke exposes gaps in outdoor worker protections

The CDC's new social media misinformation war

hotspot

AstraZeneca stays mum on Medicare drug pricing negotiations

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Bill would stop addiction treatment from triggering child abuse inquiry

Top private equity targets in 2023: cardiology, clinical trials, lasers

Phenylephrine and the overlooked value of the placebo effect

focus

focus

hotspot

focus